Embed Size (px)
Citation preview
1ST PRODUCTION OF[18F]F-PSMA @INCART
Congratulation to the Instituto Nacional del Cáncer Rosa Emilia Sánchez Pérez de Tavares (INCART) for their first production of [18F]F-PSMA-1007 using IBA Synthera® platform!
The nuclear medicine department will now give access to an efficient radiotracer for prostate cancer diagnosis for patients in the Dominican Republic.
RIGGING OF A CYCLONE®
KIUBE @SICHUAN
The Cyclone® KIUBE is now placed in its vault at Sichuan Province Cyclotron Medical Science Co., Ltd. in Chengdu in China. It will soon be ready to start producing radioisotopes used for cancer diagnosis and other critical diseases.
RADIOPHARMA SOLUTIONSNEWSLETTER N°25- AUTUMN 2020
Sylvain Savaria Vice President NA [email protected]
Li ChenSales Director [email protected]
Claudia Ochoa Vice President Western Europe & Global Chemistry Solutions [email protected]
Peter Leitner Vice President APAC [email protected]
Ambrosio Moreno Vice President LATAM [email protected]
Robert Kwizera Mugabo Sales Area Manager [email protected]
Dmitry CherkasovSales&Marketing Director Russia&[email protected]
IBA RadioPharma SolutionsChemin du cyclotron, 3 1348 Louvain-la-Neuve Belgium
Tél. : +32 10 201 275 Fax : + 32 10 47 59 00 [email protected]
IBA WORLDWIDE
iba-RadiopharmaSolutions.com
CHEMISTRY
SUCCESS STORIES
INCREASING DEMAND FOR HIGH ENERGY CYCLOTRONS
What will you learn from the webinar ?
Use of PET Imaging companion radiopharmaceutical in theranostics. By Lisa Bodei.
Evolving evidence-base for PSMA Theranostics to improve outcomes for men with prostate cancer. By Professor Michael Hofman.
3 NEW FIELD SERVICES ENGINEERS ARE JOINING THE TEAM!
Because software is a key component in a product, IBA invested in an extensive upgrade to enhance users experience in routine production as well as research.
Multi-platform
You can control all your Synthera®* platforms with one computer.
Open source software
Gives you maximum flexibility to create new recipes for free.
Highest regulatory compliance
As the software is in accordance with 21 CFR part 11 (Complete audit trail, Electronic signatures, Archives and backups), you have a complete traceability.
User-friendly
A completely intuitive interface for ease of operation of the system.
*Synthera®+, Synthera®+ HPLC, Synthera® V2, Synthera® Extension, Synthera® HPLC
NEXT MEETINGS
Due to the COVID-19 crisis, many events are cancelled or postponed. Don’t hesitate to contact us! The team will be happy to assist you remotely. [email protected]
After passing through the IBA assembly hall, the first Rhodotron® TT300-HE was rigged in its temporary house in an underground vault in Louvain-la-Neuve. The new 40 MeV accelerator will be tested and tuned during 4 months by the IBA’s R&D team before being shipped to its final destination in Wisconsin, USA.
By using high-energy electrons from the Rhodotron® to produce molybdenum-99, Northstar will be able to avoid the use of uranium and propose an innovant and optimized way to deliver technetium-99, the most widely used radio-isotope for medical diagnostics.
A NEW RHODOTRON® TO PRODUCE MOLYBDENUM-99
NEW SYNTHERA®+ SOFTWARE MAX EASE OF USE AND THE HIGHEST COMPLIANCE
68Ge 123I 68Ge 123I82Rb
Increased interest in Germanium-68/Gallium-68 and Strontium 82/ Rubidium 82 generators is driving the demand for high energy cyclotrons. Moreover, physics research projects, such as the Rare isotope Accelerator complex for ON-line experiments (RAON) project in South Korea, are contributing to the increased demand.
In 2016, IBA and Zevacor established a new record with a 70 MeV cyclotron site acceptance test received only 10 months after its delivery (see video)! Since then, 3 more Cyclone® 70 systems were acquired; one is currently under installation at A to Z Isotopes (USA, Indiana) and two others; iThemba Labs (South Africa) and RAON (South Korea) will soon be delivered.
In addition, IRE selected IBA to install a new 30MeV cyclotron that will enable them to produce Germanium-68, for the Germanium-68/ Gallium-68 generators, for which demand is rapidly growing (see press release). Two other 30 MeV cyclotrons are currently under production and will soon be shipped.
With over 30 Cyclone® 30 installed and 6 Cyclone® 70 sold all over the world, IBA is recognized as preferred vendor and undisputed leader in high energy cyclotrons.
Cyclone® 70 is a variable energy cyclotron that accelerates protons from 30 to 70 MeV with 750µA current. This cyclotron is optimized for
production of 82Sr & 68Ge for generators as well as 123I.
Cyclone® 30 is a variable-energy cyclotron that accelerates protons from 15 to 30 MeV, optionally capable to deliver deuteron and alpha (-XP). This machine is optimized for large scale production of 68Ge and 123I as well as 211At with the XP option.
More about IBA cyclotrons
The Cyclone® KIUBE (300µA version) has been successfully installed at Nukleon Nuclear Technology in Turkey. Thanks to this high capacity cyclotron, the radiopharmacy will be able to reach a daily production of 30Ci of 18F. Congratulations to the whole team involved.
I N S TA L L AT I O N O F T H E C YC LO N E ® 7 0 @ A T O Z ISOTOPES
The IBA 70 MeV Cyclone® 70 has been successfully rigged and assembled at A to Z Isotopes in Bunker Hill, Indiana (watch the video). This 140 tons cyclotron system is under installation. It will be used to produce radiopharmaceuticals for oncology, cardiology and other critical diseases.
INSTALLATION CYCLONE®
KIUBE @NUKLEON
MEET US @EANM DIGITAL MEETING
Our team of experts will be happy to chat with you about your radiopharma production needs at EANM annual meeting! Come by our virtual booth to chat or book a meeting. More info: eanm20.eanm.org
DID YOU MISS OUR WEBINARS? WATCH THE RECORDINGS.
Prof. Michael Hofman
Peter MacCallum Cancer Centre in Melbourne
Lisa Bodei, MD, PhD
Memorial Sloan Kettering Cancer Center
Theranostics and PET Imaging Diagnostics
The role of PET imaging in Neurodegenerative Diseases
What will you learn from the webinar ?
Amyloid PET Imaging: What are we waiting for? By Dr. Dubroff.
Tau imaging in typical and atypical Alzheimer’s disease. By Dr. Pedro Rosa-Neto.
Dr. Pedro Rosa-NetoProfessor of Neurology, Neurosurgery and Psychiatry at McGill University.
Dr. Jacob DubroffAssistant Professor of Radiology,Hospital of the University of Pennsylvania
Watch the recordings
Welcome to Charles Luyckx, Robin Hennaut and Vincent Degey (left to right) our 3 new field service engineers who will be working on the Cyclone® KIUBE and the Cyclone® 18.
NEURO
ONCO
211At
Cyclone® 30 Cyclone® 70
